-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
British scientists recently divided the disease into six different "types" that could help treat the new coronavirus, according to a report by Euronews.
researchers say this could help doctors better target patient-specific treatment and allow them to predict the level of care patients will need next.
the study, conducted by King's College London, analysed data from about 1,600 new crown virus infections in the UK and the US, who regularly recorded their symptoms in a tracking app in March and April.
the results of the study, patients on the 5th day of infection with the virus, the patient developed six different sets of symptoms. Carole Sudre, lead researcher at King's College London,
, said: 'This surveillance method helps us understand how this infectious disease develops in every patient so that they can get the best treatment.
" Sudre said all those who recorded symptoms experienced headaches and loss of smell, but as the disease progressed, a range of other symptoms emerged, including confusion, abdominal pain and breathing difficulties.
results were divided into 6 groups by order of symptom severity: A, influenza, no fever: headache, loss of smell, muscle pain, cough, sore throat, chest pain, no fever; B, influenza, fever; Cough, fever, hoarseness, chest pain, fatigue; E, severe secondary, confusion: headache, loss of smell, loss of appetite, cough, fever, hoarse voice, sore throat, chest pain, fatigue, confusion, muscle pain;
the first three groups were more common in younger and healthier patients, while the latter three group were more likely to have "severe" symptoms in older patients or those with diabetes, lung disease and obesity.
researchers found that only 1.5 percent of patients in group A, 4.4 percent of group B and 3.3 percent of group C needed breathing support, such as extra oxygen or ventilators.
in the last three groups, patients were significantly more likely to need respiratory support, by 8.6%, 9.9% and 19.8%, respectively.
at the same time, nearly half of patients in group F ended up in hospital, compared with 16 per cent in Group A. Claire Steves, from King's College London, said the findings were important for the care and monitoring of those most vulnerable to the virus.
Steve says that if you can predict which group these people belong to on day five, there will be time to support them and early interventions, such as monitoring oxygen and blood sugar levels, to make sure they are properly hydrated, and can provide simple care at home, avoid hospitalization and slow down.
in the study, there were 462 patients in Group A, the largest proportion of participants, 315 patients in Group B, 216 in Group C, 280 in Group D, 213 in Group E and 167 in Group F.
, the study has not yet been reviewed by industry experts.
source: China News Network !-- content display ends - !-- to determine whether the login ends.